PARIS, April 29, 2014 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports results for the first-quarter of 2014. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and R&D pipeline.
Watch video interview and read transcript:
Topics covered in the interview include:
- Q1 2014 Results
- Late-stage pipeline
- Animal Health
- Multiple Sclerosis
- R&D Newsflow
- Capital Allocation
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Company website: http://www.sanofi.com